PFKFB4 and posterior cortical atrophy: In addition, following a loss-of-function genetic screen, the glycolytic 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) enzyme was identified as an essential gene for PCa cell survival and evaluated as a potential therapeutic target for PCa treatment [48].